D-0661-2020 Class II Terminated
FDA drug recall D-0661-2020 was initiated by AVKARE Inc. on Jan 7, 2020 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: High out of specification results for related compounds. The recall status is terminated (terminated Jul 14, 2021). Affected quantity: 3,989 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 22, 2020
- Initiation Date
- Jan 7, 2020
- Termination Date
- Jul 14, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,989 cartons
Product description
Dutasteride Capsules, 0.5 mg, 30 Capsules (6 X 5) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-282-13.
Reason for recall
Failed Impurities/Degradation Specifications: High out of specification results for related compounds.
Distribution pattern
Nationwide in the USA.
Code information
Lots: 25246, Exp. 02/2021; 24532, Exp. 10/2020; 23647, Exp. 06/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0661-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026